blinatumomab
amgen,astellas
['leusm', 'ph+ all', 'blinatumomab']
the success of blinatumomab/tki in ph+ all makes me very happy but also very sad as it is inaccessible in many lmics and will probably remain so for years to come. the global equity gap widens with most success stories. #ash22 #leusm
Associate Professor @UANL Monterrey, Mexico. Interested in HSCT, acute leukemia in LMIC. ASTCT. LABMT. ASH. AMEH. SMTT. #bmtsm #leusm #mmsm #lymsm #GlobalBMT